<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37176630</PMID><DateRevised><Year>2024</Year><Month>06</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>28</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Long-Term Effects of SARS-CoV-2 in the Brain: Clinical Consequences and Molecular Mechanisms.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">3190</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm12093190</ELocationID><Abstract><AbstractText>Numerous investigations have demonstrated significant and long-lasting neurological manifestations of COVID-19. It has been suggested that as many as four out of five patients who sustained COVID-19 will show one or several neurological symptoms that can last months after the infection has run its course. Neurological symptoms are most common in people who are less than 60 years of age, while encephalopathy is more common in those over 60. Biological mechanisms for these neurological symptoms need to be investigated and may include both direct and indirect effects of the virus on the brain and spinal cord. Individuals with Alzheimer's disease (AD) and related dementia, as well as persons with Down syndrome (DS), are especially vulnerable to COVID-19, but the biological reasons for this are not clear. Investigating the neurological consequences of COVID-19 is an urgent emerging medical need, since close to 700 million people worldwide have now had COVID-19 at least once. It is likely that there will be a new burden on healthcare and the economy dealing with the long-term neurological consequences of severe SARS-CoV-2 infections and long COVID, even in younger generations. Interestingly, neurological symptoms after an acute infection are strikingly similar to the symptoms observed after a mild traumatic brain injury (mTBI) or concussion, including dizziness, balance issues, anosmia, and headaches. The possible convergence of biological pathways involved in both will be discussed. The current review is focused on the most commonly described neurological symptoms, as well as the possible molecular mechanisms involved.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Granholm</LastName><ForeName>Ann-Charlotte</ForeName><Initials>AC</Initials><AffiliationInfo><Affiliation>Department of Neurosurgery, University of Colorado Anschutz Medical Campus, Denver, CO 80045-0511, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 AG071228</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG061566</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>RF1 AG070153</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P01 AG014449</GrantID><Acronym>AG</Acronym><Agency>NIA NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01AG061566</GrantID><Acronym>GF</Acronym><Agency>NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Down syndrome</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">concussion</Keyword><Keyword MajorTopicYN="N">infectious disease and brain</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">neurotrauma</Keyword></KeywordList><CoiStatement>The author declares no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>3</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>4</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>4</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>13</Day><Hour>15</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>5</Month><Day>13</Day><Hour>15</Hour><Minute>13</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>5</Month><Day>13</Day><Hour>1</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37176630</ArticleId><ArticleId IdType="pmc">PMC10179128</ArticleId><ArticleId IdType="doi">10.3390/jcm12093190</ArticleId><ArticleId IdType="pii">jcm12093190</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Shereen M.A., Khan S., Kazmi A., Bashir N., Siddique R. COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. J. Adv. Res. 2020;24:91&#x2013;98. doi: 10.1016/j.jare.2020.03.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jare.2020.03.005</ArticleId><ArticleId IdType="pmc">PMC7113610</ArticleId><ArticleId IdType="pubmed">32257431</ArticleId></ArticleIdList></Reference><Reference><Citation>De Lusignan S., Lopez Bernal J., Zambon M., Akinyemi O., Amirthalingam G., Andrews N., Borrow R., Byford R., Charlett A., Dabrera G., et al. Emergence of a Novel Coronavirus (COVID-19): Protocol for Extending Surveillance Used by the Royal College of General Practitioners Research and Surveillance Centre and Public Health England. JMIR Public Health Surveill. 2020;6:e18606. doi: 10.2196/18606.</Citation><ArticleIdList><ArticleId IdType="doi">10.2196/18606</ArticleId><ArticleId IdType="pmc">PMC7124955</ArticleId><ArticleId IdType="pubmed">32240095</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang X., Wei F., Hu L., Wen L., Chen K. Epidemiology and Clinical Characteristics of COVID-19. Arch. Iran. Med. 2020;23:268&#x2013;271. doi: 10.34172/aim.2020.09.</Citation><ArticleIdList><ArticleId IdType="doi">10.34172/aim.2020.09</ArticleId><ArticleId IdType="pubmed">32271601</ArticleId></ArticleIdList></Reference><Reference><Citation>Kooraki S., Hosseiny M., Myers L., Gholamrezanezhad A. Coronavirus (COVID-19) Outbreak: What the Department of Radiology Should Know. J. Am. Coll. Radiol. 2020;17:447&#x2013;451. doi: 10.1016/j.jacr.2020.02.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacr.2020.02.008</ArticleId><ArticleId IdType="pmc">PMC7102595</ArticleId><ArticleId IdType="pubmed">32092296</ArticleId></ArticleIdList></Reference><Reference><Citation>Okba N.M.A., Muller M.A., Li W., Wang C., GeurtsvanKessel C.H., Corman V.M., Lamers M.M., Sikkema R.S., de Bruin E., Chandler F.D., et al. Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease Patients. Emerg. Infect. Dis. 2020;26:1478&#x2013;1488. doi: 10.3201/eid2607.200841.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2607.200841</ArticleId><ArticleId IdType="pmc">PMC7323511</ArticleId><ArticleId IdType="pubmed">32267220</ArticleId></ArticleIdList></Reference><Reference><Citation>Palacios Cruz M., Santos E., Velazquez Cervantes M.A., Leon Juarez M. COVID-19, a worldwide public health emergency. Rev. Clin. Esp. 2020;221:55&#x2013;61. doi: 10.1016/j.rce.2020.03.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.rce.2020.03.001</ArticleId><ArticleId IdType="pmc">PMC7173827</ArticleId><ArticleId IdType="pubmed">33998479</ArticleId></ArticleIdList></Reference><Reference><Citation>Wouk J., Rechenchoski D.Z., Rodrigues B.C.D., Ribelato E.V., Faccin-Galhardi L.C. Viral infections and their relationship to neurological disorders. Arch. Virol. 2021;221:55&#x2013;61. doi: 10.1007/s00705-021-04959-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-021-04959-6</ArticleId><ArticleId IdType="pmc">PMC7838016</ArticleId><ArticleId IdType="pubmed">33502593</ArticleId></ArticleIdList></Reference><Reference><Citation>De Chiara G., Marcocci M.E., Sgarbanti R., Civitelli L., Ripoli C., Piacentini R., Garaci E., Grassi C., Palamara A.T. Infectious agents and neurodegeneration. Mol. Neurobiol. 2012;46:614&#x2013;638. doi: 10.1007/s12035-012-8320-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-012-8320-7</ArticleId><ArticleId IdType="pmc">PMC3496540</ArticleId><ArticleId IdType="pubmed">22899188</ArticleId></ArticleIdList></Reference><Reference><Citation>Bagetta G., Nistico G., Bowery N.G. Prevention by the NMDA receptor antagonist, MK801 of neuronal loss produced by tetanus toxin in the rat hippocampus. Br. J. Pharmacol. 1990;101:776&#x2013;780. doi: 10.1111/j.1476-5381.1990.tb14156.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1476-5381.1990.tb14156.x</ArticleId><ArticleId IdType="pmc">PMC1917860</ArticleId><ArticleId IdType="pubmed">2150767</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou L., Miranda-Saksena M., Saksena N.K. Viruses and neurodegeneration. Virol. J. 2013;10:172. doi: 10.1186/1743-422X-10-172.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-10-172</ArticleId><ArticleId IdType="pmc">PMC3679988</ArticleId><ArticleId IdType="pubmed">23724961</ArticleId></ArticleIdList></Reference><Reference><Citation>Majde J.A. Neuroinflammation resulting from covert brain invasion by common viruses&#x2014;A potential role in local and global neurodegeneration. Med. Hypotheses. 2010;75:204&#x2013;213. doi: 10.1016/j.mehy.2010.02.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2010.02.023</ArticleId><ArticleId IdType="pmc">PMC2897933</ArticleId><ArticleId IdType="pubmed">20236772</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirtipal N., Kumar S., Dubey S.K., Dwivedi V.D., Gireesh Babu K., Maly P., Bharadwaj S. Understanding on the possible routes for SARS-CoV-2 invasion via ACE2 in the host linked with multiple organs damage. Infect. Genet. Evol. 2022;99:105254. doi: 10.1016/j.meegid.2022.105254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.meegid.2022.105254</ArticleId><ArticleId IdType="pmc">PMC8863418</ArticleId><ArticleId IdType="pubmed">35217145</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen R., Wang K., Yu J., Howard D., French L., Chen Z., Wen C., Xu Z. The Spatial and Cell-Type Distribution of SARS-CoV-2 Receptor ACE2 in the Human and Mouse Brains. Front. Neurol. 2020;11:573095. doi: 10.3389/fneur.2020.573095.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2020.573095</ArticleId><ArticleId IdType="pmc">PMC7855591</ArticleId><ArticleId IdType="pubmed">33551947</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding Q., Shults N.V., Gychka S.G., Harris B.T., Suzuki Y.J. Protein Expression of Angiotensin-Converting Enzyme 2 (ACE2) is Upregulated in Brains with Alzheimer&#x2019;s Disease. Int. J. Mol. Sci. 2021;22:1687. doi: 10.3390/ijms22041687.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms22041687</ArticleId><ArticleId IdType="pmc">PMC7914443</ArticleId><ArticleId IdType="pubmed">33567524</ArticleId></ArticleIdList></Reference><Reference><Citation>Hernandez V.S., Zetter M.A., Guerra E.C., Hernandez-Araiza I., Karuzin N., Hernandez-Perez O.R., Eiden L.E., Zhang L. ACE2 expression in rat brain: Implications for COVID-19 associated neurological manifestations. Exp. Neurol. 2021;345:113837. doi: 10.1016/j.expneurol.2021.113837.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2021.113837</ArticleId><ArticleId IdType="pmc">PMC8361001</ArticleId><ArticleId IdType="pubmed">34400158</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiao J., Li W., Bao J., Peng Q., Wen D., Wang J., Sun B. The expression of SARS-CoV-2 receptor ACE2 and CD147, and protease TMPRSS2 in human and mouse brain cells and mouse brain tissues. Biochem. Biophys. Res. Commun. 2020;533:867&#x2013;871. doi: 10.1016/j.bbrc.2020.09.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2020.09.042</ArticleId><ArticleId IdType="pmc">PMC7489930</ArticleId><ArticleId IdType="pubmed">33008593</ArticleId></ArticleIdList></Reference><Reference><Citation>Clough E., Inigo J., Chandra D., Chaves L., Reynolds J.L., Aalinkeel R., Schwartz S.A., Khmaladze A., Mahajan S.D. Mitochondrial Dynamics in SARS-CoV-2 Spike Protein Treated Human Microglia: Implications for Neuro-COVID. J. Neuroimmune Pharmacol. 2021;16:770&#x2013;784. doi: 10.1007/s11481-021-10015-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-021-10015-6</ArticleId><ArticleId IdType="pmc">PMC8487226</ArticleId><ArticleId IdType="pubmed">34599743</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Chen X., Jia L., Zhang Y. Potential mechanism of SARS-CoV-2-associated central and peripheral nervous system impairment. Acta Neurol. Scand. 2022;146:225&#x2013;236. doi: 10.1111/ane.13657.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ane.13657</ArticleId><ArticleId IdType="pmc">PMC9349396</ArticleId><ArticleId IdType="pubmed">35699161</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindskog C., Mear L., Virhammar J., Fallmar D., Kumlien E., Hesselager G., Casar-Borota O., Rostami E. Protein Expression Profile of ACE2 in the Normal and COVID-19-Affected Human Brain. J. Proteome Res. 2022;21:2137&#x2013;2145. doi: 10.1021/acs.jproteome.2c00184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.2c00184</ArticleId><ArticleId IdType="pmc">PMC9364976</ArticleId><ArticleId IdType="pubmed">35901083</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong G.U., Lyu J., Kim K.D., Chung Y.C., Yoon G.Y., Lee S., Hwang I., Shin W.H., Ko J., Lee J.Y., et al. SARS-CoV-2 Infection of Microglia Elicits Proinflammatory Activation and Apoptotic Cell Death. Microbiol. Spectr. 2022;10:e0109122. doi: 10.1128/spectrum.01091-22.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/spectrum.01091-22</ArticleId><ArticleId IdType="pmc">PMC9241873</ArticleId><ArticleId IdType="pubmed">35510852</ArticleId></ArticleIdList></Reference><Reference><Citation>Netland J., Meyerholz D.K., Moore S., Cassell M., Perlman S. Severe acute respiratory syndrome coronavirus infection causes neuronal death in the absence of encephalitis in mice transgenic for human ACE2. J. Virol. 2008;82:7264&#x2013;7275. doi: 10.1128/JVI.00737-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00737-08</ArticleId><ArticleId IdType="pmc">PMC2493326</ArticleId><ArticleId IdType="pubmed">18495771</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandez-Castaneda A., Lu P., Geraghty A.C., Song E., Lee M.H., Wood J., O&#x2019;Dea M.R., Dutton S., Shamardani K., Nwangwu K., et al. Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. Cell. 2022;185:2452&#x2013;2468.e16. doi: 10.1016/j.cell.2022.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2022.06.008</ArticleId><ArticleId IdType="pmc">PMC9189143</ArticleId><ArticleId IdType="pubmed">35768006</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilinska K., Jakubowska P., Von Bartheld C.S., Butowt R. Expression of the SARS-CoV-2 Entry Proteins, ACE2 and TMPRSS2, in Cells of the Olfactory Epithelium: Identification of Cell Types and Trends with Age. ACS Chem. Neurosci. 2020;11:1555&#x2013;1562. doi: 10.1021/acschemneuro.0c00210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00210</ArticleId><ArticleId IdType="pmc">PMC7241737</ArticleId><ArticleId IdType="pubmed">32379417</ArticleId></ArticleIdList></Reference><Reference><Citation>Burks S.M., Rosas-Hernandez H., Alenjandro Ramirez-Lee M., Cuevas E., Talpos J.C. Can SARS-CoV-2 infect the central nervous system via the olfactory bulb or the blood-brain barrier? Brain Behav. Immun. 2021;95:7&#x2013;14. doi: 10.1016/j.bbi.2020.12.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.12.031</ArticleId><ArticleId IdType="pmc">PMC7836942</ArticleId><ArticleId IdType="pubmed">33412255</ArticleId></ArticleIdList></Reference><Reference><Citation>Abbasi A.Z., Kiyani D.A., Hamid S.M., Saalim M., Fahim A., Jalal N. Spiking dependence of SARS-CoV-2 pathogenicity on TMPRSS2. J. Med. Virol. 2021;93:4205&#x2013;4218. doi: 10.1002/jmv.26911.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.26911</ArticleId><ArticleId IdType="pmc">PMC8014076</ArticleId><ArticleId IdType="pubmed">33638460</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffmann M., Kleine-Weber H., Schroeder S., Kruger N., Herrler T., Erichsen S., Schiergens T.S., Herrler G., Wu N.H., Nitsche A., et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181:271&#x2013;280.e278. doi: 10.1016/j.cell.2020.02.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.02.052</ArticleId><ArticleId IdType="pmc">PMC7102627</ArticleId><ArticleId IdType="pubmed">32142651</ArticleId></ArticleIdList></Reference><Reference><Citation>Wettstein L., Kirchhoff F., Munch J. The Transmembrane Protease TMPRSS2 as a Therapeutic Target for COVID-19 Treatment. Int. J. Mol. Sci. 2022;23:1351. doi: 10.3390/ijms23031351.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23031351</ArticleId><ArticleId IdType="pmc">PMC8836196</ArticleId><ArticleId IdType="pubmed">35163273</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinduja A., Moutairou A., Calvet J.H. Sudomotor dysfunction in patients recovered from COVID-19. Neurophysiol. Clin. 2021;51:193&#x2013;196. doi: 10.1016/j.neucli.2021.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neucli.2021.01.003</ArticleId><ArticleId IdType="pmc">PMC7835104</ArticleId><ArticleId IdType="pubmed">33551341</ArticleId></ArticleIdList></Reference><Reference><Citation>Pizzanelli C., Milano C., Canovetti S., Tagliaferri E., Turco F., Verdenelli S., Nesti L., Franchi M., Bonanni E., Menichetti F., et al. Autoimmune limbic encephalitis related to SARS-CoV-2 infection: Case-report and review of the literature. Brain Behav. Immun. Health. 2021;12:100210. doi: 10.1016/j.bbih.2021.100210.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2021.100210</ArticleId><ArticleId IdType="pmc">PMC7830195</ArticleId><ArticleId IdType="pubmed">33521691</ArticleId></ArticleIdList></Reference><Reference><Citation>Emmerton D., Abdelhafiz A.H. Care for Older People with Dementia During COVID-19 Pandemic. SN Compr. Clin. Med. 2021;3:437&#x2013;443. doi: 10.1007/s42399-020-00715-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-020-00715-0</ArticleId><ArticleId IdType="pmc">PMC7837877</ArticleId><ArticleId IdType="pubmed">33527095</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu Y., Travaglio M., Popovic R., Leal N.S., Martins L.M. Alzheimer&#x2019;s and Parkinson&#x2019;s Diseases Predict Different COVID-19 Outcomes: A UK Biobank Study. Geriatrics. 2021;6:10. doi: 10.3390/geriatrics6010010.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/geriatrics6010010</ArticleId><ArticleId IdType="pmc">PMC7839041</ArticleId><ArticleId IdType="pubmed">33530357</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong S.J., Yong M.H., Teoh S.L., Soga T., Parhar I., Chew J., Lim W.L. The Hippocampal Vulnerability to Herpes Simplex Virus Type I Infection: Relevance to Alzheimer&#x2019;s Disease and Memory Impairment. Front. Cell. Neurosci. 2021;15:695738. doi: 10.3389/fncel.2021.695738.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2021.695738</ArticleId><ArticleId IdType="pmc">PMC8414573</ArticleId><ArticleId IdType="pubmed">34483839</ArticleId></ArticleIdList></Reference><Reference><Citation>Readhead B., Haure-Mirande J.V., Funk C.C., Richards M.A., Shannon P., Haroutunian V., Sano M., Liang W.S., Beckmann N.D., Price N.D., et al. Multiscale Analysis of Independent Alzheimer&#x2019;s Cohorts Finds Disruption of Molecular, Genetic, and Clinical Networks by Human Herpesvirus. Neuron. 2018;99:64&#x2013;82.e7. doi: 10.1016/j.neuron.2018.05.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2018.05.023</ArticleId><ArticleId IdType="pmc">PMC6551233</ArticleId><ArticleId IdType="pubmed">29937276</ArticleId></ArticleIdList></Reference><Reference><Citation>Galeotti C., Bayry J. Autoimmune and inflammatory diseases following COVID-19. Nat. Rev. Rheumatol. 2020;16:413&#x2013;414. doi: 10.1038/s41584-020-0448-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41584-020-0448-7</ArticleId><ArticleId IdType="pmc">PMC7271827</ArticleId><ArticleId IdType="pubmed">32499548</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Beltagi M., Saeed N.K., Bediwy A.S. COVID-19 disease and autoimmune disorders: A mutual pathway. World J. Methodol. 2022;12:200&#x2013;223. doi: 10.5662/wjm.v12.i4.200.</Citation><ArticleIdList><ArticleId IdType="doi">10.5662/wjm.v12.i4.200</ArticleId><ArticleId IdType="pmc">PMC9350728</ArticleId><ArticleId IdType="pubmed">36159097</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhagavati S. Autoimmune Disorders of the Nervous System: Pathophysiology, Clinical Features, and Therapy. Front. Neurol. 2021;12:664664. doi: 10.3389/fneur.2021.664664.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.664664</ArticleId><ArticleId IdType="pmc">PMC8079742</ArticleId><ArticleId IdType="pubmed">33935958</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez Y., Novelli L., Rojas M., De Santis M., Acosta-Ampudia Y., Monsalve D.M., Ramirez-Santana C., Costanzo A., Ridgway W.M., Ansari A.A., et al. Autoinflammatory and autoimmune conditions at the crossroad of COVID-19. J. Autoimmun. 2020;114:102506. doi: 10.1016/j.jaut.2020.102506.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2020.102506</ArticleId><ArticleId IdType="pmc">PMC7296326</ArticleId><ArticleId IdType="pubmed">32563547</ArticleId></ArticleIdList></Reference><Reference><Citation>Tufan A., Avanoglu Guler A., Matucci-Cerinic M. COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs. Turk. J. Med. Sci. 2020;50:620&#x2013;632. doi: 10.3906/sag-2004-168.</Citation><ArticleIdList><ArticleId IdType="doi">10.3906/sag-2004-168</ArticleId><ArticleId IdType="pmc">PMC7195984</ArticleId><ArticleId IdType="pubmed">32299202</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hazmi A. Challenges presented by MERS corona virus, and SARS corona virus to global health. Saudi J. Biol. Sci. 2016;23:507&#x2013;511. doi: 10.1016/j.sjbs.2016.02.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sjbs.2016.02.019</ArticleId><ArticleId IdType="pmc">PMC4890194</ArticleId><ArticleId IdType="pubmed">27298584</ArticleId></ArticleIdList></Reference><Reference><Citation>Verstrepen K., Baisier L., De Cauwer H. Neurological manifestations of COVID-19, SARS and MERS. Acta Neurol. Belg. 2020;120:1051&#x2013;1060. doi: 10.1007/s13760-020-01412-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13760-020-01412-4</ArticleId><ArticleId IdType="pmc">PMC7303437</ArticleId><ArticleId IdType="pubmed">32562214</ArticleId></ArticleIdList></Reference><Reference><Citation>Anwar M.M., Badawi A.M., Eltablawy N.A. Can the coronavirus infection penetrates the brain resulting in sudden anosmia followed by severe neurological disorders? eNeurologicalSci. 2020;21:100290. doi: 10.1016/j.ensci.2020.100290.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ensci.2020.100290</ArticleId><ArticleId IdType="pmc">PMC7657010</ArticleId><ArticleId IdType="pubmed">33200104</ArticleId></ArticleIdList></Reference><Reference><Citation>Desforges M., Le Coupanec A., Dubeau P., Bourgouin A., Lajoie L., Dube M., Talbot P.J. Human Coronaviruses and Other Respiratory Viruses: Underestimated Opportunistic Pathogens of the Central Nervous System? Viruses. 2019;12:14. doi: 10.3390/v12010014.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v12010014</ArticleId><ArticleId IdType="pmc">PMC7020001</ArticleId><ArticleId IdType="pubmed">31861926</ArticleId></ArticleIdList></Reference><Reference><Citation>Ibrahim Fouad G. The neuropathological impact of COVID-19: A review. Bull. Natl. Res. Cent. 2021;45:19. doi: 10.1186/s42269-020-00478-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s42269-020-00478-7</ArticleId><ArticleId IdType="pmc">PMC7802990</ArticleId><ArticleId IdType="pubmed">33456304</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y., Xu X., Chen Z., Duan J., Hashimoto K., Yang L., Liu C., Yang C. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav. Immun. 2020;87:18&#x2013;22. doi: 10.1016/j.bbi.2020.03.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.03.031</ArticleId><ArticleId IdType="pmc">PMC7146689</ArticleId><ArticleId IdType="pubmed">32240762</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavallieri F., Sellner J., Zedde M., Moro E. Neurologic complications of coronavirus and other respiratory viral infections. Handb. Clin. Neurol. 2022;189:331&#x2013;358. doi: 10.1016/B978-0-323-91532-8.00004-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-323-91532-8.00004-5</ArticleId><ArticleId IdType="pmc">PMC9418023</ArticleId><ArticleId IdType="pubmed">36031313</ArticleId></ArticleIdList></Reference><Reference><Citation>McEntire C.R.S., Song K.W., McInnis R.P., Rhee J.Y., Young M., Williams E., Wibecan L.L., Nolan N., Nagy A.M., Gluckstein J., et al. Neurologic Manifestations of the World Health Organization&#x2019;s List of Pandemic and Epidemic Diseases. Front. Neurol. 2021;12:634827. doi: 10.3389/fneur.2021.634827.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2021.634827</ArticleId><ArticleId IdType="pmc">PMC7937722</ArticleId><ArticleId IdType="pubmed">33692745</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J., Radke J., Dittmayer C., Franz J., Thomas C., Mothes R., Laue M., Schneider J., Brunink S., Greuel S., et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat. Neurosci. 2021;24:168&#x2013;175. doi: 10.1038/s41593-020-00758-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00758-5</ArticleId><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Harapan B.N., Yoo H.J. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19) J. Neurol. 2021;268:3059&#x2013;3071. doi: 10.1007/s00415-021-10406-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-021-10406-y</ArticleId><ArticleId IdType="pmc">PMC7826147</ArticleId><ArticleId IdType="pubmed">33486564</ArticleId></ArticleIdList></Reference><Reference><Citation>Maiese A., Manetti A.C., Bosetti C., Del Duca F., La Russa R., Frati P., Di Paolo M., Turillazzi E., Fineschi V. SARS-CoV-2 and the brain: A review of the current knowledge on neuropathology in COVID-19. Brain Pathol. 2021;31:e13013. doi: 10.1111/bpa.13013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.13013</ArticleId><ArticleId IdType="pmc">PMC8420197</ArticleId><ArticleId IdType="pubmed">34390282</ArticleId></ArticleIdList></Reference><Reference><Citation>Pajo A.T., Espiritu A.I., Apor A., Jamora R.D.G. Neuropathologic findings of patients with COVID-19: A systematic review. Neurol. Sci. 2021;42:1255&#x2013;1266. doi: 10.1007/s10072-021-05068-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10072-021-05068-7</ArticleId><ArticleId IdType="pmc">PMC7822400</ArticleId><ArticleId IdType="pubmed">33483885</ArticleId></ArticleIdList></Reference><Reference><Citation>Thakur K.T., Miller E.H., Glendinning M.D., Al-Dalahmah O., Banu M.A., Boehme A.K., Boubour A.L., Bruce S.S., Chong A.M., Claassen J., et al. COVID-19 neuropathology at Columbia University Irving Medical Center/New York Presbyterian Hospital. Brain. 2021;144:2696&#x2013;2708. doi: 10.1093/brain/awab148.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab148</ArticleId><ArticleId IdType="pmc">PMC8083258</ArticleId><ArticleId IdType="pubmed">33856027</ArticleId></ArticleIdList></Reference><Reference><Citation>Arbour N., Day R., Newcombe J., Talbot P.J. Neuroinvasion by human respiratory coronaviruses. J. Virol. 2000;74:8913&#x2013;8921. doi: 10.1128/JVI.74.19.8913-8921.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.74.19.8913-8921.2000</ArticleId><ArticleId IdType="pmc">PMC102086</ArticleId><ArticleId IdType="pubmed">10982334</ArticleId></ArticleIdList></Reference><Reference><Citation>Hui D.S.C., Zumla A. Severe Acute Respiratory Syndrome: Historical, Epidemiologic, and Clinical Features. Infect. Dis. Clin. North. Am. 2019;33:869&#x2013;889. doi: 10.1016/j.idc.2019.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idc.2019.07.001</ArticleId><ArticleId IdType="pmc">PMC7127569</ArticleId><ArticleId IdType="pubmed">31668196</ArticleId></ArticleIdList></Reference><Reference><Citation>Pormohammad A., Ghorbani S., Khatami A., Farzi R., Baradaran B., Turner D.L., Turner R.J., Bahr N.C., Idrovo J.P. Comparison of confirmed COVID-19 with SARS and MERS cases&#x2014;Clinical characteristics, laboratory findings, radiographic signs and outcomes: A systematic review and meta-analysis. Rev. Med. Virol. 2020;30:e2112. doi: 10.1002/rmv.2112.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2112</ArticleId><ArticleId IdType="pmc">PMC7300470</ArticleId><ArticleId IdType="pubmed">32502331</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahase E. Coronavirus COVID-19 has killed more people than SARS and MERS combined, despite lower case fatality rate. BMJ. 2020;368:m641. doi: 10.1136/bmj.m641.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m641</ArticleId><ArticleId IdType="pubmed">32071063</ArticleId></ArticleIdList></Reference><Reference><Citation>Guedj E., Campion J.Y., Dudouet P., Kaphan E., Bregeon F., Tissot-Dupont H., Guis S., Barthelemy F., Habert P., Ceccaldi M., et al. (18)F-FDG brain PET hypometabolism in patients with long COVID. Eur. J. Nucl. Med. Mol. Imaging. 2021;48:2823&#x2013;2833. doi: 10.1007/s00259-021-05215-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-021-05215-4</ArticleId><ArticleId IdType="pmc">PMC7837643</ArticleId><ArticleId IdType="pubmed">33501506</ArticleId></ArticleIdList></Reference><Reference><Citation>Grossberg A.N., Koza L.A., Ledreux A., Prusmack C., Krishnamurthy H.K., Jayaraman V., Granholm A.C., Linseman D.A. A multiplex chemiluminescent immunoassay for serological profiling of COVID-19-positive symptomatic and asymptomatic patients. Nat. Commun. 2021;12:740. doi: 10.1038/s41467-021-21040-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21040-7</ArticleId><ArticleId IdType="pmc">PMC7854643</ArticleId><ArticleId IdType="pubmed">33531472</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirfazeli F.S., Sarabi-Jamab A., Jahanbakhshi A., Kordi A., Javadnia P., Shariat S.V., Aloosh O., Almasi-Dooghaee M., Faiz S.H.R. Neuropsychiatric manifestations of COVID-19 can be clustered in three distinct symptom categories. Sci. Rep. 2020;10:20957. doi: 10.1038/s41598-020-78050-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-78050-6</ArticleId><ArticleId IdType="pmc">PMC7708626</ArticleId><ArticleId IdType="pubmed">33262404</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweid A., Hammoud B., Bekelis K., Missios S., Tjoumakaris S.I., Gooch M.R., Herial N.A., Zarzour H., Romo V., DePrince M., et al. Cerebral ischemic and hemorrhagic complications of coronavirus disease 2019. Int. J. Stroke. 2020;15:733&#x2013;742. doi: 10.1177/1747493020937189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1747493020937189</ArticleId><ArticleId IdType="pmc">PMC7534206</ArticleId><ArticleId IdType="pubmed">32501751</ArticleId></ArticleIdList></Reference><Reference><Citation>Aghayari Sheikh Neshin S., Shahjouei S., Koza E., Friedenberg I., Khodadadi F., Sabra M., Kobeissy F., Ansari S., Tsivgoulis G., Li J., et al. Stroke in SARS-CoV-2 Infection: A Pictorial Overview of the Pathoetiology. Front. Cardiovasc. Med. 2021;8:649922. doi: 10.3389/fcvm.2021.649922.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2021.649922</ArticleId><ArticleId IdType="pmc">PMC8039152</ArticleId><ArticleId IdType="pubmed">33855053</ArticleId></ArticleIdList></Reference><Reference><Citation>Mutiawati E., Fahriani M., Mamada S.S., Fajar J.K., Frediansyah A., Maliga H.A., Ilmawan M., Emran T.B., Ophinni Y., Ichsan I., et al. Anosmia and dysgeusia in SARS-CoV-2 infection: Incidence and effects on COVID-19 severity and mortality, and the possible pathobiology mechanisms&#x2014;A systematic review and meta-analysis. F1000Research. 2021;10:40. doi: 10.12688/f1000research.28393.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.12688/f1000research.28393.1</ArticleId><ArticleId IdType="pmc">PMC7993408</ArticleId><ArticleId IdType="pubmed">33824716</ArticleId></ArticleIdList></Reference><Reference><Citation>Pua Torrejon R.C., Ordono Saiz M.V., Gonzalez Alguacil E., Furones Garcia M., Cantarin Extremera V., Ruiz Falco M.L., Soto Insuga V. Smell and Taste Dysfunction in Pediatric Patients With SARS-CoV-2 Infection. Pediatr. Neurol. 2022;136:28&#x2013;33. doi: 10.1016/j.pediatrneurol.2022.07.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pediatrneurol.2022.07.006</ArticleId><ArticleId IdType="pmc">PMC9343071</ArticleId><ArticleId IdType="pubmed">36084419</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortiz-Prado E., Simbana-Rivera K., Gomez-Barreno L., Rubio-Neira M., Guaman L.P., Kyriakidis N.C., Muslin C., Jaramillo A.M.G., Barba-Ostria C., Cevallos-Robalino D., et al. Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review. Diagn. Microbiol. Infect. Dis. 2020;98:115094. doi: 10.1016/j.diagmicrobio.2020.115094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.diagmicrobio.2020.115094</ArticleId><ArticleId IdType="pmc">PMC7260568</ArticleId><ArticleId IdType="pubmed">32623267</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Yang W., Chen F., Cui L. COVID-19 and cognitive impairment: Neuroinvasive and blood&#x2013;brain barrier dysfunction. J. Neuroinflammation. 2022;19:222. doi: 10.1186/s12974-022-02579-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-022-02579-8</ArticleId><ArticleId IdType="pmc">PMC9450840</ArticleId><ArticleId IdType="pubmed">36071466</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyson B., Shahein A., Erdodi L., Tyson L., Tyson R., Ghomi R., Agarwal P. Delirium as a Presenting Symptom of COVID-19. Cogn. Behav. Neurol. 2022;35:123&#x2013;129. doi: 10.1097/WNN.0000000000000305.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WNN.0000000000000305</ArticleId><ArticleId IdType="pmc">PMC9148631</ArticleId><ArticleId IdType="pubmed">35486533</ArticleId></ArticleIdList></Reference><Reference><Citation>Caronna E., Ballve A., Llaurado A., Gallardo V.J., Ariton D.M., Lallana S., Lopez Maza S., Olive Gadea M., Quibus L., Restrepo J.L., et al. Headache: A striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution. Cephalalgia. 2020;40:1410&#x2013;1421. doi: 10.1177/0333102420965157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0333102420965157</ArticleId><ArticleId IdType="pmc">PMC7645597</ArticleId><ArticleId IdType="pubmed">33146036</ArticleId></ArticleIdList></Reference><Reference><Citation>Rahman S., Montero M.T.V., Rowe K., Kirton R., Kunik F., Jr. Epidemiology, pathogenesis, clinical presentations, diagnosis and treatment of COVID-19: A review of current evidence. Expert. Rev. Clin. Pharmacol. 2021;14:601&#x2013;621. doi: 10.1080/17512433.2021.1902303.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17512433.2021.1902303</ArticleId><ArticleId IdType="pmc">PMC8095162</ArticleId><ArticleId IdType="pubmed">33705239</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathore V., Galhotra A., Pal R., Sahu K.K. COVID-19 Pandemic and Children: A Review. J. Pediatr. Pharmacol. Ther. 2020;25:574&#x2013;585. doi: 10.5863/1551-6776-25.7.574.</Citation><ArticleIdList><ArticleId IdType="doi">10.5863/1551-6776-25.7.574</ArticleId><ArticleId IdType="pmc">PMC7541032</ArticleId><ArticleId IdType="pubmed">33041712</ArticleId></ArticleIdList></Reference><Reference><Citation>Rando H.M., Bennett T.D., Byrd J.B., Bramante C., Callahan T.J., Chute C.G., Davis H.E., Deer R., Gagnier J., Koraishy F.M., et al. Challenges in defining Long COVID: Striking differences across literature, Electronic Health Records, and patient-reported information. medRxiv. 2021 doi: 10.1101/2021.03.20.21253896.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.20.21253896</ArticleId></ArticleIdList></Reference><Reference><Citation>Tana C., Bentivegna E., Cho S.J., Harriott A.M., Garcia-Azorin D., Labastida-Ramirez A., Ornello R., Raffaelli B., Beltran E.R., Ruscheweyh R., et al. Long COVID headache. J. Headache Pain. 2022;23:93. doi: 10.1186/s10194-022-01450-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s10194-022-01450-8</ArticleId><ArticleId IdType="pmc">PMC9340759</ArticleId><ArticleId IdType="pubmed">35915417</ArticleId></ArticleIdList></Reference><Reference><Citation>Kakovan M., Ghorbani Shirkouhi S., Zarei M., Andalib S. Stroke Associated with COVID-19 Vaccines. J. Stroke Cerebrovasc. Dis. 2022;31:106440. doi: 10.1016/j.jstrokecerebrovasdis.2022.106440.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jstrokecerebrovasdis.2022.106440</ArticleId><ArticleId IdType="pmc">PMC8894799</ArticleId><ArticleId IdType="pubmed">35339857</ArticleId></ArticleIdList></Reference><Reference><Citation>Kantarcioglu B., Iqbal O., Lewis J., Carter C.A., Singh M., Lievano F., Ligocki M., Jeske W., Adiguzel C., Gerotziafas G.T., et al. An Update on the Status of Vaccine Development for SARS-CoV-2 Including Variants. Practical Considerations for COVID-19 Special Populations. Clin. Appl. Thromb. Hemost. 2022;28:10760296211056648. doi: 10.1177/10760296211056648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10760296211056648</ArticleId><ArticleId IdType="pmc">PMC8851053</ArticleId><ArticleId IdType="pubmed">35167393</ArticleId></ArticleIdList></Reference><Reference><Citation>Sriwastava S., Sharma K., Khalid S.H., Bhansali S., Shrestha A.K., Elkhooly M., Srivastava S., Khan E., Jaiswal S., Wen S. COVID-19 Vaccination and Neurological Manifestations: A Review of Case Reports and Case Series. Brain Sci. 2022;12:407. doi: 10.3390/brainsci12030407.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci12030407</ArticleId><ArticleId IdType="pmc">PMC8946610</ArticleId><ArticleId IdType="pubmed">35326363</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhandari B., Rayamajhi G., Lamichhane P., Shenoy A.K. Adverse Events following Immunization with COVID-19 Vaccines: A Narrative Review. Biomed. Res. Int. 2022;2022:2911333. doi: 10.1155/2022/2911333.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/2911333</ArticleId><ArticleId IdType="pmc">PMC9398801</ArticleId><ArticleId IdType="pubmed">36017393</ArticleId></ArticleIdList></Reference><Reference><Citation>Pyne J.D., Brickman A.M. The Impact of the COVID-19 Pandemic on Dementia Risk: Potential Pathways to Cognitive Decline. Neurodegener. Dis. 2021;21:1&#x2013;23. doi: 10.1159/000518581.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000518581</ArticleId><ArticleId IdType="pmc">PMC8678181</ArticleId><ArticleId IdType="pubmed">34348321</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrantes F.J. Central Nervous System Targets and Routes for SARS-CoV-2: Current Views and New Hypotheses. ACS Chem. Neurosci. 2020;11:2793&#x2013;2803. doi: 10.1021/acschemneuro.0c00434.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.0c00434</ArticleId><ArticleId IdType="pubmed">32845609</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng Q., Rasool R.U., Russell R.M., Natesan R., Asangani I.A. Targeting androgen regulation of TMPRSS2 and ACE2 as a therapeutic strategy to combat COVID-19. iScience. 2021;24:102254. doi: 10.1016/j.isci.2021.102254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2021.102254</ArticleId><ArticleId IdType="pmc">PMC7919514</ArticleId><ArticleId IdType="pubmed">33681723</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni W., Yang X., Yang D., Bao J., Li R., Xiao Y., Hou C., Wang H., Liu J., Yang D., et al. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Crit. Care. 2020;24:422. doi: 10.1186/s13054-020-03120-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03120-0</ArticleId><ArticleId IdType="pmc">PMC7356137</ArticleId><ArticleId IdType="pubmed">32660650</ArticleId></ArticleIdList></Reference><Reference><Citation>Urmila A., Rashmi P., Nilam G., Subhash B. Recent Advances in the Endogenous Brain Renin-Angiotensin System and Drugs Acting on It. J. Renin Angiotensin Aldosterone Syst. 2021;2021:9293553. doi: 10.1155/2021/9293553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2021/9293553</ArticleId><ArticleId IdType="pmc">PMC8651430</ArticleId><ArticleId IdType="pubmed">34925551</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X.L., Iwanami J., Min L.J., Tsukuda K., Nakaoka H., Bai H.Y., Shan B.S., Kan-No H., Kukida M., Chisaka T., et al. Deficiency of angiotensin-converting enzyme 2 causes deterioration of cognitive function. NPJ Aging Mech. Dis. 2016;2:16024. doi: 10.1038/npjamd.2016.24.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/npjamd.2016.24</ArticleId><ArticleId IdType="pmc">PMC5515001</ArticleId><ArticleId IdType="pubmed">28721275</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S., Liu J., Miura Y., Tanabe C., Maeda T., Terayama Y., Turner A.J., Zou K., Komano H. Conversion of Abeta43 to Abeta40 by the successive action of angiotensin-converting enzyme 2 and angiotensin-converting enzyme. J. Neurosci. Res. 2014;92:1178&#x2013;1186. doi: 10.1002/jnr.23404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.23404</ArticleId><ArticleId IdType="pubmed">24823497</ArticleId></ArticleIdList></Reference><Reference><Citation>Parit R., Jayavel S. Association of ACE inhibitors and Angiotensin type II blockers with ACE2 overexpression in COVID-19 comorbidities: A pathway-based analytical study. Eur. J. Pharmacol. 2021;896:173899. doi: 10.1016/j.ejphar.2021.173899.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2021.173899</ArticleId><ArticleId IdType="pmc">PMC7839513</ArticleId><ArticleId IdType="pubmed">33508281</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett R.E., Esparza T.J., Lewis H.A., Kim E., Mac Donald C.L., Sullivan P.M., Brody D.L. Human apolipoprotein E4 worsens acute axonal pathology but not amyloid-beta immunoreactivity after traumatic brain injury in 3xTG-AD mice. J. Neuropathol. Exp. Neurol. 2013;72:396&#x2013;403. doi: 10.1097/NEN.0b013e31828e24ab.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e31828e24ab</ArticleId><ArticleId IdType="pmc">PMC7355224</ArticleId><ArticleId IdType="pubmed">23584199</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen F., Chen Y., Wang Y., Ke Q., Cui L. The COVID-19 pandemic and Alzheimer&#x2019;s disease: Mutual risks and mechanisms. Transl. Neurodegener. 2022;11:40. doi: 10.1186/s40035-022-00316-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40035-022-00316-y</ArticleId><ArticleId IdType="pmc">PMC9464468</ArticleId><ArticleId IdType="pubmed">36089575</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurki S.N., Kantonen J., Kaivola K., Hokkanen L., Mayranpaa M.I., Puttonen H., FinnGen, Martola J., Poyhonen M., Kero M., et al. APOE epsilon4 associates with increased risk of severe COVID-19, cerebral microhaemorrhages and post-COVID mental fatigue: A Finnish biobank, autopsy and clinical study. Acta Neuropathol. Commun. 2021;9:199. doi: 10.1186/s40478-021-01302-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-021-01302-7</ArticleId><ArticleId IdType="pmc">PMC8696243</ArticleId><ArticleId IdType="pubmed">34949230</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterson A., Marengoni A., Shenkin S., MacLullich A. Delirium in COVID-19: Common, distressing and linked with poor outcomes... can we do better? Age Ageing. 2021;50:1436&#x2013;1438. doi: 10.1093/ageing/afab153.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ageing/afab153</ArticleId><ArticleId IdType="pmc">PMC8344520</ArticleId><ArticleId IdType="pubmed">34174069</ArticleId></ArticleIdList></Reference><Reference><Citation>Voormolen D.C., Cnossen M.C., Polinder S., von Steinbuechel N., Vos P.E., Haagsma J.A. Divergent Classification Methods of Post-Concussion Syndrome after Mild Traumatic Brain Injury: Prevalence Rates, Risk Factors, and Functional Outcome. J. Neurotrauma. 2018;35:1233&#x2013;1241. doi: 10.1089/neu.2017.5257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2017.5257</ArticleId><ArticleId IdType="pmc">PMC6909759</ArticleId><ArticleId IdType="pubmed">29350085</ArticleId></ArticleIdList></Reference><Reference><Citation>Bullock G.S., Emery C.A., Nelson V.R., Prats-Uribe A., Gilliland R.G., Thigpen C.A., Shanley E. Higher rates of concussion following COVID-19 infection in high school athletes. Br. J. Sport. Med. 2023;57:590&#x2013;594. doi: 10.1136/bjsports-2022-106436.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bjsports-2022-106436</ArticleId><ArticleId IdType="pubmed">36754589</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodnar C.N., Watson J.B., Higgins E.K., Quan N., Bachstetter A.D. Inflammatory Regulation of CNS Barriers After Traumatic Brain Injury: A Tale Directed by Interleukin-1. Front. Immunol. 2021;12:688254. doi: 10.3389/fimmu.2021.688254.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.688254</ArticleId><ArticleId IdType="pmc">PMC8176952</ArticleId><ArticleId IdType="pubmed">34093593</ArticleId></ArticleIdList></Reference><Reference><Citation>Welcome M.O., Mastorakis N.E. Neuropathophysiology of coronavirus disease 2019: Neuroinflammation and blood brain barrier disruption are critical pathophysiological processes that contribute to the clinical symptoms of SARS-CoV-2 infection. Inflammopharmacology. 2021;29:939&#x2013;963. doi: 10.1007/s10787-021-00806-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-021-00806-x</ArticleId><ArticleId IdType="pmc">PMC8021940</ArticleId><ArticleId IdType="pubmed">33822324</ArticleId></ArticleIdList></Reference><Reference><Citation>DeKosky S.T., Kochanek P.M., Valadka A.B., Clark R.S.B., Chou S.H., Au A.K., Horvat C., Jha R.M., Mannix R., Wisniewski S.R., et al. Blood Biomarkers for Detection of Brain Injury in COVID-19 Patients. J. Neurotrauma. 2021;38:1&#x2013;43. doi: 10.1089/neu.2020.7332.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2020.7332</ArticleId><ArticleId IdType="pmc">PMC7757533</ArticleId><ArticleId IdType="pubmed">33115334</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi K., Zhang J., Dong J.F., Shi F.D. Dissemination of brain inflammation in traumatic brain injury. Cell. Mol. Immunol. 2019;16:523&#x2013;530. doi: 10.1038/s41423-019-0213-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-019-0213-5</ArticleId><ArticleId IdType="pmc">PMC6804599</ArticleId><ArticleId IdType="pubmed">30846842</ArticleId></ArticleIdList></Reference><Reference><Citation>Fotuhi M., Mian A., Meysami S., Raji C.A. Neurobiology of COVID-19. J. Alzheimers Dis. 2020;76:3&#x2013;19. doi: 10.3233/JAD-200581.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-200581</ArticleId><ArticleId IdType="pmc">PMC7660990</ArticleId><ArticleId IdType="pubmed">32538857</ArticleId></ArticleIdList></Reference><Reference><Citation>Sikora E., Bielak-Zmijewska A., Dudkowska M., Krzystyniak A., Mosieniak G., Wesierska M., Wlodarczyk J. Cellular Senescence in Brain Aging. Front. Aging Neurosci. 2021;13:646924. doi: 10.3389/fnagi.2021.646924.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2021.646924</ArticleId><ArticleId IdType="pmc">PMC7959760</ArticleId><ArticleId IdType="pubmed">33732142</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattson M.P., Arumugam T.V. Hallmarks of Brain Aging: Adaptive and Pathological Modification by Metabolic States. Cell Metab. 2018;27:1176&#x2013;1199. doi: 10.1016/j.cmet.2018.05.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2018.05.011</ArticleId><ArticleId IdType="pmc">PMC6039826</ArticleId><ArticleId IdType="pubmed">29874566</ArticleId></ArticleIdList></Reference><Reference><Citation>Karnik M., Beeraka N.M., Uthaiah C.A., Nataraj S.M., Bettadapura A.D.S., Aliev G., Madhunapantula S.V. A Review on SARS-CoV-2-Induced Neuroinflammation, Neurodevelopmental Complications, and Recent Updates on the Vaccine Development. Mol. Neurobiol. 2021;58:4535&#x2013;4563. doi: 10.1007/s12035-021-02399-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-021-02399-6</ArticleId><ArticleId IdType="pmc">PMC8179092</ArticleId><ArticleId IdType="pubmed">34089508</ArticleId></ArticleIdList></Reference><Reference><Citation>Vargas G., Medeiros Geraldo L.H., Gedeao Salomao N., Viana Paes M., Regina Souza Lima F., Carvalho Alcantara Gomes F. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and glial cells: Insights and perspectives. Brain Behav. Immun. Health. 2020;7:100127. doi: 10.1016/j.bbih.2020.100127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2020.100127</ArticleId><ArticleId IdType="pmc">PMC7423575</ArticleId><ArticleId IdType="pubmed">32838339</ArticleId></ArticleIdList></Reference><Reference><Citation>Mavrikaki M., Lee J.D., Solomon I.H., Slack F.J. Severe COVID-19 induces molecular signatures of aging in the human brain. medRxiv. 2021 doi: 10.1101/2021.11.24.21266779.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.11.24.21266779</ArticleId><ArticleId IdType="pubmed">37118539</ArticleId></ArticleIdList></Reference><Reference><Citation>Idrees D., Kumar V. SARS-CoV-2 spike protein interactions with amyloidogenic proteins: Potential clues to neurodegeneration. Biochem. Biophys. Res. Commun. 2021;554:94&#x2013;98. doi: 10.1016/j.bbrc.2021.03.100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2021.03.100</ArticleId><ArticleId IdType="pmc">PMC7988450</ArticleId><ArticleId IdType="pubmed">33789211</ArticleId></ArticleIdList></Reference><Reference><Citation>Mysiris D.S., Vavougios G.D., Karamichali E., Papoutsopoulou S., Stavrou V.T., Papayianni E., Boutlas S., Mavridis T., Foka P., Zarogiannis S.G., et al. Post-COVID-19 Parkinsonism and Parkinson&#x2019;s Disease Pathogenesis: The Exosomal Cargo Hypothesis. Int. J. Mol. Sci. 2022;23:9739. doi: 10.3390/ijms23179739.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23179739</ArticleId><ArticleId IdType="pmc">PMC9456372</ArticleId><ArticleId IdType="pubmed">36077138</ArticleId></ArticleIdList></Reference><Reference><Citation>Groh N., Buhler A., Huang C., Li K.W., van Nierop P., Smit A.B., Fandrich M., Baumann F., David D.C. Age-Dependent Protein Aggregation Initiates Amyloid-beta Aggregation. Front. Aging Neurosci. 2017;9:138. doi: 10.3389/fnagi.2017.00138.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2017.00138</ArticleId><ArticleId IdType="pmc">PMC5434662</ArticleId><ArticleId IdType="pubmed">28567012</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan C.H., Prajapati D.P., Ritter M.L., DeConde A.S. Persistent Smell Loss Following Undetectable SARS-CoV-2. Otolaryngol. Head Neck Surg. 2020;63:923&#x2013;925. doi: 10.1177/0194599820934769.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0194599820934769</ArticleId><ArticleId IdType="pmc">PMC8809452</ArticleId><ArticleId IdType="pubmed">32513065</ArticleId></ArticleIdList></Reference><Reference><Citation>Dell&#x2019;Era V., Farri F., Garzaro G., Gatto M., Aluffi Valletti P., Garzaro M. Smell and taste disorders during COVID-19 outbreak: A cross-sectional study on 355 patients. Head Neck. 2020;42:1591&#x2013;1596. doi: 10.1002/hed.26288.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/hed.26288</ArticleId><ArticleId IdType="pmc">PMC7300750</ArticleId><ArticleId IdType="pubmed">32524707</ArticleId></ArticleIdList></Reference><Reference><Citation>Menni C., Valdes A.M., Freidin M.B., Sudre C.H., Nguyen L.H., Drew D.A., Ganesh S., Varsavsky T., Cardoso M.J., El-Sayed Moustafa J.S., et al. Real-time tracking of self-reported symptoms to predict potential COVID-19. Nat. Med. 2020;26:1037&#x2013;1040. doi: 10.1038/s41591-020-0916-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0916-2</ArticleId><ArticleId IdType="pmc">PMC7751267</ArticleId><ArticleId IdType="pubmed">32393804</ArticleId></ArticleIdList></Reference><Reference><Citation>Song E., Zhang C., Israelow B., Lu-Culligan A., Prado A.V., Skriabine S., Lu P., Weizman O.E., Liu F., Dai Y., et al. Neuroinvasion of SARS-CoV-2 in human and mouse brain. J. Exp. Med. 2021;218:e20202135. doi: 10.1084/jem.20202135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20202135</ArticleId><ArticleId IdType="pmc">PMC7808299</ArticleId><ArticleId IdType="pubmed">33433624</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu J., Lazartigues E. Expression of ACE2 in Human Neurons Supports the Neuro-Invasive Potential of COVID-19 Virus. Cell. Mol. Neurobiol. 2020;42:305&#x2013;309. doi: 10.1007/s10571-020-00915-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-020-00915-1</ArticleId><ArticleId IdType="pmc">PMC7334623</ArticleId><ArticleId IdType="pubmed">32623546</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuler B.A., Habermann A.C., Plosa E.J., Taylor C.J., Jetter C., Negretti N.M., Kapp M.E., Benjamin J.T., Gulleman P., Nichols D.S., et al. Age-determined expression of priming protease TMPRSS2 and localization of SARS-CoV-2 in lung epithelium. J. Clin. Investig. 2021;131:e140766. doi: 10.1172/JCI140766.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI140766</ArticleId><ArticleId IdType="pmc">PMC7773394</ArticleId><ArticleId IdType="pubmed">33180746</ArticleId></ArticleIdList></Reference><Reference><Citation>Uversky V.N., Elrashdy F., Aljadawi A., Ali S.M., Khan R.H., Redwan E.M. Severe acute respiratory syndrome coronavirus 2 infection reaches the human nervous system: How? J. Neurosci. Res. 2020;99:750&#x2013;777. doi: 10.1002/jnr.24752.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.24752</ArticleId><ArticleId IdType="pmc">PMC7753416</ArticleId><ArticleId IdType="pubmed">33217763</ArticleId></ArticleIdList></Reference><Reference><Citation>Kunnumakkara A.B., Rana V., Parama D., Banik K., Girisa S., Sahu H., Thakur K.K., Dutta U., Garodia P., Gupta S.C., et al. COVID-19, cytokines, inflammation, and spices: How are they related? Life Sci. 2021;284:119201. doi: 10.1016/j.lfs.2021.119201.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lfs.2021.119201</ArticleId><ArticleId IdType="pmc">PMC7884924</ArticleId><ArticleId IdType="pubmed">33607159</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrawal S., Farfel J.M., Arfanakis K., Al-Harthi L., Shull T., Teppen T.L., Evia A.M., Patel M.B., Ely E.W., Leurgans S.E., et al. Brain autopsies of critically ill COVID-19 patients demonstrate heterogeneous profile of acute vascular injury, inflammation and age-linked chronic brain diseases. Acta Neuropathol. Commun. 2022;10:186. doi: 10.1186/s40478-022-01493-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-022-01493-7</ArticleId><ArticleId IdType="pmc">PMC9758667</ArticleId><ArticleId IdType="pubmed">36528671</ArticleId></ArticleIdList></Reference><Reference><Citation>Plini E.R.G., O&#x2019;Hanlon E., Boyle R., Sibilia F., Rikhye G., Kenney J., Whelan R., Melnychuk M.C., Robertson I.H., Dockree P.M. Examining the Role of the Noradrenergic Locus Coeruleus for Predicting Attention and Brain Maintenance in Healthy Old Age and Disease: An MRI Structural Study for the Alzheimer&#x2019;s Disease Neuroimaging Initiative. Cells. 2021;10:1829. doi: 10.3390/cells10071829.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10071829</ArticleId><ArticleId IdType="pmc">PMC8306442</ArticleId><ArticleId IdType="pubmed">34359997</ArticleId></ArticleIdList></Reference><Reference><Citation>Bocci M., Oudenaarden C., Saenz-Sarda X., Simren J., Eden A., Sjolund J., Moller C., Gisslen M., Zetterberg H., Englund E., et al. Infection of Brain Pericytes Underlying Neuropathology of COVID-19 Patients. Int. J. Mol. Sci. 2021;22:11622. doi: 10.3390/ijms222111622.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms222111622</ArticleId><ArticleId IdType="pmc">PMC8583965</ArticleId><ArticleId IdType="pubmed">34769052</ArticleId></ArticleIdList></Reference><Reference><Citation>Serrano G.E., Walker J.E., Arce R., Glass M.J., Vargas D., Sue L.I., Intorcia A.J., Nelson C.M., Oliver J., Papa J., et al. Mapping of SARS-CoV-2 Brain Invasion and Histopathology in COVID-19 Disease. medRxiv. 2021 doi: 10.1101/2021.02.15.21251511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.02.15.21251511</ArticleId></ArticleIdList></Reference><Reference><Citation>Quan D., Luna Wong L., Shallal A., Madan R., Hamdan A., Ahdi H., Daneshvar A., Mahajan M., Nasereldin M., Van Harn M., et al. Impact of Race and Socioeconomic Status on Outcomes in Patients Hospitalized with COVID-19. J. Gen. Intern. Med. 2021;36:1302&#x2013;1309. doi: 10.1007/s11606-020-06527-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11606-020-06527-1</ArticleId><ArticleId IdType="pmc">PMC7840076</ArticleId><ArticleId IdType="pubmed">33506402</ArticleId></ArticleIdList></Reference><Reference><Citation>Maedler K., Dharmadhikari G., Schumann D.M., Storling J. Interleukin-targeted therapy for metabolic syndrome and type 2 diabetes. In: Schwanstecher M., editor. Diabetes-Perspectives in Drug Therapy. Volume 203. Springer; Berlin/Heidelberg, Germany: 2011. pp. 257&#x2013;278. Handbook of Experimental Pharmacology.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-3-642-17214-4_11</ArticleId><ArticleId IdType="pubmed">21484575</ArticleId></ArticleIdList></Reference><Reference><Citation>Argaw A.T., Zhang Y., Snyder B.J., Zhao M.L., Kopp N., Lee S.C., Raine C.S., Brosnan C.F., John G.R. IL-1beta regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program. J. Immunol. 2006;177:5574&#x2013;5584. doi: 10.4049/jimmunol.177.8.5574.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.177.8.5574</ArticleId><ArticleId IdType="pubmed">17015745</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman W.J. Cytokines regulate expression of the type 1 interleukin-1 receptor in rat hippocampal neurons and glia. Exp. Neurol. 2001;168:23&#x2013;31. doi: 10.1006/exnr.2000.7595.</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/exnr.2000.7595</ArticleId><ArticleId IdType="pubmed">11170718</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam S.M., Huang X., Shui G. Neurological aspects of SARS-CoV-2 infection: Lipoproteins and exosomes as Trojan horses. Trends Endocrinol. Metab. 2022;33:554&#x2013;568. doi: 10.1016/j.tem.2022.04.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tem.2022.04.011</ArticleId><ArticleId IdType="pmc">PMC9058057</ArticleId><ArticleId IdType="pubmed">35613979</ArticleId></ArticleIdList></Reference><Reference><Citation>Pesce E., Manfrini N., Cordiglieri C., Santi S., Bandera A., Gobbini A., Gruarin P., Favalli A., Bombaci M., Cuomo A., et al. Exosomes Recovered From the Plasma of COVID-19 Patients Expose SARS-CoV-2 Spike-Derived Fragments and Contribute to the Adaptive Immune Response. Front. Immunol. 2021;12:785941. doi: 10.3389/fimmu.2021.785941.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.785941</ArticleId><ArticleId IdType="pmc">PMC8801440</ArticleId><ArticleId IdType="pubmed">35111156</ArticleId></ArticleIdList></Reference><Reference><Citation>Barile L., Vassalli G. Exosomes: Therapy delivery tools and biomarkers of diseases. Pharmacol. Ther. 2017;174:63&#x2013;78. doi: 10.1016/j.pharmthera.2017.02.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2017.02.020</ArticleId><ArticleId IdType="pubmed">28202367</ArticleId></ArticleIdList></Reference><Reference><Citation>DeLeo A.M., Ikezu T. Extracellular Vesicle Biology in Alzheimer&#x2019;s Disease and Related Tauopathy. J. Neuroimmune Pharmacol. 2018;13:292&#x2013;308. doi: 10.1007/s11481-017-9768-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11481-017-9768-z</ArticleId><ArticleId IdType="pmc">PMC5972041</ArticleId><ArticleId IdType="pubmed">29185187</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamlett E.D., Ledreux A., Potter H., Chial H.J., Patterson D., Espinosa J.M., Bettcher B.M., Granholm A.C. Exosomal biomarkers in Down syndrome and Alzheimer&#x2019;s disease. Free Radic. Biol. Med. 2018;114:110&#x2013;121. doi: 10.1016/j.freeradbiomed.2017.08.028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2017.08.028</ArticleId><ArticleId IdType="pmc">PMC6135098</ArticleId><ArticleId IdType="pubmed">28882786</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamlett E.D., Goetzl E.J., Ledreux A., Vasilevko V., Boger H.A., LaRosa A., Clark D., Carroll S.L., Carmona-Iragui M., Fortea J., et al. Neuronal exosomes reveal Alzheimer&#x2019;s disease biomarkers in Down syndrome. Alzheimers Dement. 2016;13:541&#x2013;549. doi: 10.1016/j.jalz.2016.08.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2016.08.012</ArticleId><ArticleId IdType="pmc">PMC5812672</ArticleId><ArticleId IdType="pubmed">27755974</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurunathan S., Kang M.H., Kim J.H. Diverse Effects of Exosomes on COVID-19: A Perspective of Progress From Transmission to Therapeutic Developments. Front. Immunol. 2021;12:716407. doi: 10.3389/fimmu.2021.716407.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.716407</ArticleId><ArticleId IdType="pmc">PMC8355618</ArticleId><ArticleId IdType="pubmed">34394121</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H., Lu J., Liu J., Zhang G., Lu A. Advances in the discovery of exosome inhibitors in cancer. J. Enzym. Inhib. Med. Chem. 2020;35:1322&#x2013;1330. doi: 10.1080/14756366.2020.1754814.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14756366.2020.1754814</ArticleId><ArticleId IdType="pmc">PMC7717571</ArticleId><ArticleId IdType="pubmed">32543905</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiandaca M.S., Kapogiannis D., Mapstone M., Boxer A., Eitan E., Schwartz J.B., Abner E.L., Petersen R.C., Federoff H.J., Miller B.L., et al. Identification of preclinical Alzheimer&#x2019;s disease by a profile of pathogenic proteins in neurally derived blood exosomes: A case-control study. Alzheimers Dement. 2015;11:600&#x2013;607.e601. doi: 10.1016/j.jalz.2014.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2014.06.008</ArticleId><ArticleId IdType="pmc">PMC4329112</ArticleId><ArticleId IdType="pubmed">25130657</ArticleId></ArticleIdList></Reference><Reference><Citation>Goetzl E.J., Elahi F.M., Mustapic M., Kapogiannis D., Pryhoda M., Gilmore A., Gorgens K.A., Davidson B., Granholm A.C., Ledreux A. Altered levels of plasma neuron-derived exosomes and their cargo proteins characterize acute and chronic mild traumatic brain injury. FASEB J. 2019;33:5082&#x2013;5088. doi: 10.1096/fj.201802319R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201802319R</ArticleId><ArticleId IdType="pmc">PMC6436652</ArticleId><ArticleId IdType="pubmed">30605353</ArticleId></ArticleIdList></Reference><Reference><Citation>Goetzl E.J., Mustapic M., Kapogiannis D., Eitan E., Lobach I.V., Goetzl L., Schwartz J.B., Miller B.L. Cargo proteins of plasma astrocyte-derived exosomes in Alzheimer&#x2019;s disease. FASEB J. 2016;30:3853&#x2013;3859. doi: 10.1096/fj.201600756R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201600756R</ArticleId><ArticleId IdType="pmc">PMC5067254</ArticleId><ArticleId IdType="pubmed">27511944</ArticleId></ArticleIdList></Reference><Reference><Citation>Guix F.X., Corbett G.T., Cha D.J., Mustapic M., Liu W., Mengel D., Chen Z., Aikawa E., Young-Pearse T., Kapogiannis D., et al. Detection of Aggregation-Competent Tau in Neuron-Derived Extracellular Vesicles. Int. J. Mol. Sci. 2018;19:663. doi: 10.3390/ijms19030663.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19030663</ArticleId><ArticleId IdType="pmc">PMC5877524</ArticleId><ArticleId IdType="pubmed">29495441</ArticleId></ArticleIdList></Reference><Reference><Citation>Kenney K., Qu B.X., Lai C., Devoto C., Motamedi V., Walker W.C., Levin H.S., Nolen T., Wilde E.A., Diaz-Arrastia R., et al. Higher exosomal phosphorylated tau and total tau among veterans with combat-related repetitive chronic mild traumatic brain injury. Brain Inj. 2018;32:1276&#x2013;1284. doi: 10.1080/02699052.2018.1483530.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/02699052.2018.1483530</ArticleId><ArticleId IdType="pubmed">29889559</ArticleId></ArticleIdList></Reference><Reference><Citation>Li P., Kaslan M., Lee S.H., Yao J., Gao Z. Progress in Exosome Isolation Techniques. Theranostics. 2017;7:789&#x2013;804. doi: 10.7150/thno.18133.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/thno.18133</ArticleId><ArticleId IdType="pmc">PMC5327650</ArticleId><ArticleId IdType="pubmed">28255367</ArticleId></ArticleIdList></Reference><Reference><Citation>Clift A.K., Coupland C.A.C., Keogh R.H., Hemingway H., Hippisley-Cox J. COVID-19 Mortality Risk in Down Syndrome: Results From a Cohort Study Of 8 Million Adults. Ann. Intern. Med. 2020;174:572&#x2013;576. doi: 10.7326/M20-4986.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-4986</ArticleId><ArticleId IdType="pmc">PMC7592804</ArticleId><ArticleId IdType="pubmed">33085509</ArticleId></ArticleIdList></Reference><Reference><Citation>Espinosa J.M. Down Syndrome and COVID-19: A Perfect Storm? Cell. Rep. Med. 2020;1:100019. doi: 10.1016/j.xcrm.2020.100019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2020.100019</ArticleId><ArticleId IdType="pmc">PMC7252041</ArticleId><ArticleId IdType="pubmed">32501455</ArticleId></ArticleIdList></Reference><Reference><Citation>Huls A., Feany P.T., Zisman S.I., Costa A.C.S., Dierssen M., Balogh R., Bargagna S., Baumer N.T., Brandao A.C., Carfi A., et al. COVID-19 Vaccination of Individuals with Down Syndrome-Data from the Trisomy 21 Research Society Survey on Safety, Efficacy, and Factors Associated with the Decision to Be Vaccinated. Vaccines. 2022;10:530. doi: 10.3390/vaccines10040530.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10040530</ArticleId><ArticleId IdType="pmc">PMC9030605</ArticleId><ArticleId IdType="pubmed">35455279</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper S.A., Ademola T., Caslake M., Douglas E., Evans J., Greenlaw N., Haig C., Hassiotis A., Jahoda A., McConnachie A., et al. Towards onset prevention of cognition decline in adults with Down syndrome (The TOP-COG study): A pilot randomised controlled trial. Trials. 2016;17:370. doi: 10.1186/s13063-016-1370-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-016-1370-9</ArticleId><ArticleId IdType="pmc">PMC4966871</ArticleId><ArticleId IdType="pubmed">27473843</ArticleId></ArticleIdList></Reference><Reference><Citation>Real de Asua D., Parra P., Costa R., Moldenhauer F., Suarez C. A cross-sectional study of the phenotypes of obesity and insulin resistance in adults with down syndrome. Diabetes Metab. J. 2014;38:464&#x2013;471. doi: 10.4093/dmj.2014.38.6.464.</Citation><ArticleIdList><ArticleId IdType="doi">10.4093/dmj.2014.38.6.464</ArticleId><ArticleId IdType="pmc">PMC4273033</ArticleId><ArticleId IdType="pubmed">25541610</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilcock D.M., Schmitt F.A., Head E. Cerebrovascular contributions to aging and Alzheimer&#x2019;s disease in Down syndrome. Biochim. Biophys. Acta. 2016;1862:909&#x2013;914. doi: 10.1016/j.bbadis.2015.11.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2015.11.007</ArticleId><ArticleId IdType="pmc">PMC4821721</ArticleId><ArticleId IdType="pubmed">26593849</ArticleId></ArticleIdList></Reference><Reference><Citation>Illouz T., Biragyn A., Iulita M.F., Flores-Aguilar L., Dierssen M., De Toma I., Antonarakis S.E., Yu E., Herault Y., Potier M.C., et al. Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome. Front. Immunol. 2021;12:621440. doi: 10.3389/fimmu.2021.621440.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.621440</ArticleId><ArticleId IdType="pmc">PMC8267813</ArticleId><ArticleId IdType="pubmed">34248930</ArticleId></ArticleIdList></Reference><Reference><Citation>Colvin K.L., Yeager M.E. What people with Down Syndrome can teach us about cardiopulmonary disease. Eur. Respir. Rev. 2017;26:160098. doi: 10.1183/16000617.0098-2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/16000617.0098-2016</ArticleId><ArticleId IdType="pmc">PMC9489111</ArticleId><ArticleId IdType="pubmed">28223397</ArticleId></ArticleIdList></Reference><Reference><Citation>Satge D., Seidel M.G. The Pattern of Malignancies in Down Syndrome and Its Potential Context With the Immune System. Front. Immunol. 2018;9:3058. doi: 10.3389/fimmu.2018.03058.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2018.03058</ArticleId><ArticleId IdType="pmc">PMC6315194</ArticleId><ArticleId IdType="pubmed">30631328</ArticleId></ArticleIdList></Reference><Reference><Citation>Andolfo I., Russo R., Lasorsa V.A., Cantalupo S., Rosato B.E., Bonfiglio F., Frisso G., Abete P., Cassese G.M., Servillo G., et al. Common variants at 21q22.3 locus influence MX1 and TMPRSS2 gene expression and susceptibility to severe COVID-19. iScience. 2021;24:102322. doi: 10.1016/j.isci.2021.102322.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2021.102322</ArticleId><ArticleId IdType="pmc">PMC7968217</ArticleId><ArticleId IdType="pubmed">33748697</ArticleId></ArticleIdList></Reference><Reference><Citation>Lockrow J.P., Fortress A.M., Granholm A.C. Age-related neurodegeneration and memory loss in down syndrome. Curr. Gerontol. Geriatr. Res. 2012;2012:463909. doi: 10.1155/2012/463909.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2012/463909</ArticleId><ArticleId IdType="pmc">PMC3318235</ArticleId><ArticleId IdType="pubmed">22545043</ArticleId></ArticleIdList></Reference><Reference><Citation>Bras A., Rodrigues A.S., Gomes B., Rueff J. Down syndrome and microRNAs. Biomed. Rep. 2018;8:11&#x2013;16. doi: 10.3892/br.2017.1019.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/br.2017.1019</ArticleId><ArticleId IdType="pmc">PMC5780767</ArticleId><ArticleId IdType="pubmed">29403643</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasca S., Jurj A., Petrushev B., Tomuleasa C., Matei D. MicroRNA-155 Implication in M1 Polarization and the Impact in Inflammatory Diseases. Front. Immunol. 2020;11:625. doi: 10.3389/fimmu.2020.00625.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.00625</ArticleId><ArticleId IdType="pmc">PMC7174664</ArticleId><ArticleId IdType="pubmed">32351507</ArticleId></ArticleIdList></Reference><Reference><Citation>Derkow K., Rossling R., Schipke C., Kruger C., Bauer J., Fahling M., Stroux A., Schott E., Ruprecht K., Peters O., et al. Distinct expression of the neurotoxic microRNA family let-7 in the cerebrospinal fluid of patients with Alzheimer&#x2019;s disease. PLoS ONE. 2018;13:e0200602. doi: 10.1371/journal.pone.0200602.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0200602</ArticleId><ArticleId IdType="pmc">PMC6047809</ArticleId><ArticleId IdType="pubmed">30011310</ArticleId></ArticleIdList></Reference><Reference><Citation>Penarrubia A.L., Ruiz M., Porco R., Rao S.N., Juanola-Falgarona M., Manissero D., Lopez-Fontanals M., Pareja J. Multiple assays in a real-time RT-PCR SARS-CoV-2 panel can mitigate the risk of loss of sensitivity by new genomic variants during the COVID-19 outbreak. Int. J. Infect. Dis. 2020;97:225&#x2013;229. doi: 10.1016/j.ijid.2020.06.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2020.06.027</ArticleId><ArticleId IdType="pmc">PMC7289722</ArticleId><ArticleId IdType="pubmed">32535302</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>